[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@PerpetuityH2W](/creator/twitter/PerpetuityH2W) "#Q1FY26 Aggregate #DomesticFormulation Segment Revenue for XX Indian #Pharma companies stood at 31K cr. +10%YoY +12% QoQ. Highest growth: YoY: #Astrazeneca; QoQ: #FDC. #Health2Wealth #Perpetuity" [X Link](https://x.com/PerpetuityH2W/status/1965020142372585692) [@PerpetuityH2W](/creator/x/PerpetuityH2W) 2025-09-08T11:51Z 3164 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@PerpetuityH2W
"#Q1FY26 Aggregate #DomesticFormulation Segment Revenue for XX Indian #Pharma companies stood at 31K cr. +10%YoY +12% QoQ. Highest growth: YoY: #Astrazeneca; QoQ: #FDC. #Health2Wealth #Perpetuity"
X Link @PerpetuityH2W 2025-09-08T11:51Z 3164 followers, XXX engagements
/creator/twitter::1635987516150124544/posts